Mate, Really what would be the point of CGB buying Canntab or their Patents, CGB's management has already showed shareholder that they are not capable of marketing or selling the Canntab products and increasing their Revenue. How would CGB buying Canntab make benefit shareholders when they didn't even manage to sell all the product they Purchased, O that's right they they didn't pay Medcan for it, so they got it for free (until the Courts make them pay for it) Revenue and quarterlies shows they didn't sell the 400k + of product.
I do love you enthusiasm for the company, your posting style reminds me of another former Pro poster Crabbe
Cheers
CGB Price at posting:
2.1¢ Sentiment: Sell Disclosure: Not Held
